Total Payments
$2,032
2024 Payments
$256.23
Companies
26
Transactions
76
Medicare Patients
3,090
Medicare Billing
$171,972
Payment Breakdown by Category
Food & Beverage$1,553 (76.4%)
Other$478.93 (23.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,553 | 74 | 76.4% |
| Debt forgiveness | $478.93 | 2 | 23.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $614.28 | 17 | $0 (2024) |
| Welch Allyn | $263.41 | 1 | $0 (2021) |
| Baxter Healthcare | $215.52 | 1 | $0 (2022) |
| ABBVIE INC. | $128.97 | 8 | $0 (2024) |
| Lilly USA, LLC | $121.76 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $112.61 | 7 | $0 (2024) |
| Amgen Inc. | $85.70 | 6 | $0 (2023) |
| Medtronic, Inc. | $60.67 | 1 | $0 (2022) |
| Novo Nordisk Inc | $55.78 | 4 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $43.69 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $256.23 | 9 | AstraZeneca Pharmaceuticals LP ($133.18) |
| 2023 | $445.37 | 22 | AstraZeneca Pharmaceuticals LP ($129.05) |
| 2022 | $539.33 | 14 | Baxter Healthcare ($215.52) |
| 2021 | $560.99 | 14 | Welch Allyn ($263.41) |
| 2020 | $158.77 | 12 | Amarin Pharma Inc. ($40.94) |
| 2019 | $58.91 | 4 | Amgen Inc. ($29.88) |
| 2017 | $12.09 | 1 | Horizon Pharma plc ($12.09) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $16.60 | General |
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $100.74 | General |
| Category: Respiratory | ||||||
| 07/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: VACCINES | ||||||
| 04/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), FARXIGA, AIRSUPRA | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: Respiratory | ||||||
| 12/28/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: PAIN | ||||||
| 10/31/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Inflammation | ||||||
| 10/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $84.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes | ||||||
| 08/15/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Inflammation | ||||||
| 08/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/07/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.01 | General |
| Category: Opioid Analgesic | ||||||
| 06/30/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Bone Health | ||||||
| 05/01/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/27/2023 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: PAIN | ||||||
| 03/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 431 | 666 | $51,722 | $20,057 |
| 2022 | 27 | 619 | 999 | $71,538 | $31,175 |
| 2021 | 29 | 1,068 | 1,756 | $129,397 | $59,917 |
| 2020 | 34 | 972 | 1,673 | $146,793 | $60,823 |
Total Patients
3,090
Total Services
5,094
Medicare Billing
$171,972
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 138 | $31,274 | $10,646 | 34.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $3,570 | $2,116 | 59.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 28 | $4,346 | $1,398 | 32.2% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 23 | 26 | $2,210 | $1,052 | 47.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 23 | 26 | $1,586 | $754.26 | 47.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 32 | 43 | $1,290 | $707.78 | 54.9% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2023 | 31 | 42 | $1,050 | $583.80 | 55.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 56 | $2,072 | $552.21 | 26.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 27 | 36 | $1,008 | $472.32 | 46.9% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 32 | 43 | $688.00 | $380.12 | 55.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 32 | 46 | $506.00 | $378.00 | 74.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 32 | 42 | $588.00 | $319.62 | 54.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 16 | 20 | $360.00 | $190.40 | 52.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 14 | 16 | $288.00 | $165.60 | 57.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 16 | $400.00 | $121.22 | 30.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 15 | 21 | $210.00 | $110.41 | 52.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 13 | 28 | $210.00 | $86.67 | 41.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 15 | 22 | $66.00 | $22.74 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 131 | $29,475 | $10,790 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 70 | $9,380 | $3,900 | 41.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 25 | 25 | $5,250 | $3,186 | 60.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 12 | 42 | $5,040 | $2,582 | 51.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $3,180 | $1,543 | 48.5% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2022 | 17 | 22 | $1,870 | $897.81 | 48.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 37 | 52 | $1,560 | $863.74 | 55.4% |
About Dr. John Murphy, MD
Dr. John Murphy, MD is a Internal Medicine healthcare provider based in High Point, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972565646.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Murphy, MD has received a total of $2,032 in payments from pharmaceutical and medical device companies, with $256.23 received in 2024. These payments were reported across 76 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,553).
As a Medicare-enrolled provider, Murphy has provided services to 3,090 Medicare beneficiaries, totaling 5,094 services with total Medicare billing of $171,972. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pain Medicine
- Location High Point, NC
- Active Since 04/06/2006
- Last Updated 07/19/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1972565646
Products in Payments
- FARXIGA (Drug) $287.62
- None (Device) $263.41
- BREZTRI (Drug) $144.43
- VRAYLAR (Drug) $109.87
- AIRSUPRA (Drug) $100.74
- MOUNJARO (Drug) $77.88
- INTERSTIM (Device) $60.67
- XIFAXAN (Drug) $43.69
- SHINGRIX (Biological) $42.15
- Vascepa (Drug) $40.94
- BELSOMRA (Drug) $36.37
- NALOCET (Drug) $35.46
- UBRELVY (Drug) $32.96
- Otezla (Drug) $31.38
- ANORO ELLIPTA (Drug) $29.06
- Aimovig (Biological) $28.64
- Ozempic (Drug) $27.98
- Rybelsus (Drug) $27.80
- ZENPEP (Drug) $26.99
- EVENITY (Biological) $25.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in High Point
Imran Haque, M.d, M.D
Internal Medicine — Payments: $18,695
Internal Medicine $18,695
Dr. Jeffrey Yourshaw, M.d, M.D
Internal Medicine — Payments: $12,650
Internal Medicine $12,650
Dr. Oscar Florendo, M.d, M.D
Internal Medicine — Payments: $11,971
Internal Medicine $11,971
Thomas Jarrett, M.d, M.D
Internal Medicine — Payments: $9,588
Internal Medicine $9,588
Kurt Daniel, D.o, D.O
Internal Medicine — Payments: $7,198
Internal Medicine $7,198
Dr. William Smith, M.d, M.D
Internal Medicine — Payments: $6,941
Internal Medicine $6,941